“…The primary antibodies used in this study were anticalretinin (1/400, Swant) (Schwaller et al, 1993), anti-NURR1 (NR4A2 -Mouse Genome Informatics; 1/100, R&D Systems) (Hoerder-Suabedissen et al, 2009), anti-PAX6 (1/200, Covance) (Marquardt et al, 2001), anti-TBR2 (1/500, Chemicon), anti-TBR1 (1/500, Abcam) (Englund et al, 2005), anti-CUX1 (1/100, Santa Cruz Biotech. ), anti-TUJ1 (1/500, Sigma) (Lee et al, 1990), anti-chondroitin sulfate (1/200, Sigma) (Bicknese et al, 1994), anti-Ki67 (1/500, BD, Pharmingen), (Kubbutat et al, 1994), antineurogenin 2 (1/100, R&D Systems) (Lo et al, 2002), anti-BrdU (1/500, BD, Pharmingen) (Dolbeare et al, 1983) and anti-CTIP2 (1/500, Abcam) (Lai et al, 2008). The secondary antibodies were Alexa 488-or 555-conjugated goat anti-mouse, anti-rabbit or anti-rat IgG (Molecular Probes).…”